×

Transdermal compositions containing levosimendan

  • US 6,183,771 B1
  • Filed: 03/23/1999
  • Issued: 02/06/2001
  • Est. Priority Date: 07/05/1996
  • Status: Expired due to Term
First Claim
Patent Images

1. A transdermal preparation, comprising, as a therapeutically active ingredient, (−

  • )-[[4-(1,4,5,6-tetrahydro-4-methyl-6-oxo-3-pyridazinyl)phenyl]-hydrazono]propanedinitrile or a pharmaceutically acceptable salt thereof.

View all claims
  • 1 Assignment
Timeline View
Assignment View
    ×
    ×